US FDA says J&J's Ethicon issues correction related to surgical stapler
Summary
The U.S. drug regulator said on Friday Ethicon Endo-Surgery, a unit of Johnson & Johnson , issued a correction for certa...
The U.S. drug regulator said on Friday Ethicon Endo-Surgery, a unit of Johnson & Johnson , issued a correction for certain lots of a part related to its surgical stapler and classified the action as "most serious".
Related Articles
What Is Considered a Good Stock Dividend? 3 Healthcare Stocks That Fit the Bill
JNJ
PositiveNANOBIOTIX Announces New Results From a Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Combination With Immune Checkpoint Inhibitors as a 2L+ Therapy for Patients With Primary Cutaneous Melanoma Resistant to Anti-PD-1
JNJ
PositiveJ&J Painting Recognized with 2026 Consumer Choice Award for Painting Contractor in Waterloo
JNJ
Positive